tazobactam has been researched along with Enterocolitis, Pseudomembranous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cadnum, JL; Donskey, CJ; Jury, LA; Kundrapu, S; Musuuza, JS; Nerandzic, MM; Sethi, AK; Sunkesula, VC | 1 |
Ahern, JW; Alston, WK | 1 |
Corrado, OJ; Fawley, WN; Hawkey, PM; Settle, CD; Wilcox, MH | 1 |
Brown, A; Freeman, J; Wilcox, MH | 1 |
1 trial(s) available for tazobactam and Enterocolitis, Pseudomembranous
Article | Year |
---|---|
Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam.
Topics: Aged; beta-Lactamase Inhibitors; Cefotaxime; Clostridioides difficile; Cross Infection; Cross-Over Studies; Diarrhea; Drug Combinations; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Female; Humans; Male; Opportunistic Infections; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 1998 |
3 other study(ies) available for tazobactam and Enterocolitis, Pseudomembranous
Article | Year |
---|---|
Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Hospitals; Humans; Intestines; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Risk Factors; Tazobactam | 2016 |
Increase in the rate of nosocomial Clostridium difficile-associated diarrhoea during shortages of piperacillin-tazobactam and piperacillin.
Topics: Clostridioides difficile; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; United States | 2004 |
Faecal concentrations of piperacillin and tazobactam in elderly patients.
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Feces; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 2001 |